Pfizer said Monday, September 20, 2021, its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon - a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.... [Read More]
